Biphasic mesothelioma is a combination of epithelioid and sarcomatoid mesothelioma cells. This type of mesothelioma is the second most common cellular diagnosis. A patient’s prognosis heavily depends on the ratio of epithelioid to sarcomatoid cells.
What Is Biphasic Mesothelioma?
Biphasic Cell Type
Biphasic mesothelioma tumors are made up of both epithelioid mesothelioma and sarcomatoid mesothelioma cells. Biphasic mesothelioma accounts for between 20 and 30 percent of cases.
For a mesothelioma diagnosis to qualify as biphasic, both cell types must account for at least 10 percent of the cells. If the minority cell type accounts for less than 10 percent of the cells, then the disease is diagnosed as the majority type.
Characteristics of Biphasic Cells
Biphasic Mesothelioma Symptoms
Biphasic mesothelioma symptoms resemble those of epithelioid mesothelioma and sarcomatoid mesothelioma. The symptoms vary depending on if the disease is pleural or peritoneal.
Symptoms of biphasic pleural mesothelioma include:
- Pain in the chest or lower back
- Difficulty breathing and swallowing
- Pleural effusions (fluid buildup in the pleura)
Symptoms of biphasic peritoneal mesothelioma include:
- Abdominal pain
- Ascites (fluid in the abdomen)
Top Cancer Centers
Brigham and Women's Hospital
Memorial Sloan and Kettering Cancer Center
UCLA Medical Center
University of California Los Angeles Medical Center
New York, NY
Los Angeles, CA
Doctors use a technique called immunohistochemistry to diagnose mesothelioma. Once a biopsy is performed and tissue removed, experts coat the cells with dye to make the proteins in the cells more visible. These proteins are used as markers to detect if cancer is present.
Treatment for biphasic mesothelioma includes chemotherapy, radiation and surgery. New treatments, such as gene therapy and immunotherapy, are having a positive effect on patients with this cellular type of mesothelioma.
Patients with a biphasic mesothelioma largely comprised of epithelioid cells tend to have a better prognosis than those with mostly sarcomatoid cells.
A study published in the Annals of Surgical Oncology showed how cytoreduction and HIPEC is used for biphasic peritoneal mesothelioma patients. The median survival time was 6.8 years for patients who underwent a complete resection.
Another report in the Annals of Surgical Oncology showed the survival times for biphasic pleural mesothelioma patients who underwent surgery. The median overall survival for the 354 patients analyzed was 15.8 months.
A 2018 study in Clinical Lung Cancer shows the average survival time for each mesothelioma cell type:
- Biphasic patients lived for an average of 9.5 months following their diagnosis.
- Epithelioid patients, by comparison, survived for 14.5 months on average.
- Undergoing surgery lengthened the average survival time by around six months for biphasic and epithelioid patients.
There have been cases of biphasic mesothelioma patients living longer than the average survival rate. Receiving treatment from a mesothelioma specialist is the most effective way to improve a prognosis.
Last Edited: April 17, 2020.